Please wait...

Learn

Finding accredited CPD

The role of triple therapy in respiratory disease: Asthma

Description

Asthma is a common, chronic condition affecting nearly 2.8 million people in Australia, and its multi-system impact necessitates a comprehensive and up-to-date approach to patient care. This CPD activity will guide you through the latest evidence-based practices, focusing on the strategic use of triple therapy within a broader management framework.


Learning Outcomes

  1. Review the incidence and prevalence of Asthma in the Australian community
  2. Review the multi-system impact of Asthma on patients with the condition
  3. Outline current treatment and management regimes for patients with Asthma.

Details

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard. 

Provided by


CPD Activity Details
Topic
Respiratory System Diseases, General Practice and Primary Care
CAPE Aspects
_
Effective Year

Educational Activities (EA) - 1.0

Reviewing Performance (RP) - 1.0

Measuring Outcomes (MO) - 2.0

You have to log in to see the content of this module.

*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)